Cargando…
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since become a pandemic virus resulting in hundreds of thousands of deaths and deep socioeconomic implications worldwide. In recent months, effor...
Autores principales: | Galipeau, Yannick, Greig, Matthew, Liu, George, Driedger, Matt, Langlois, Marc-André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775512/ https://www.ncbi.nlm.nih.gov/pubmed/33391281 http://dx.doi.org/10.3389/fimmu.2020.610688 |
Ejemplares similares
-
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022) -
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
por: Colwill, Karen, et al.
Publicado: (2022) -
Continuous false positive results by SARS-CoV-2 rapid antigen testing: a case report
por: Galipeau, Yannick, et al.
Publicado: (2023) -
Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines
por: Demone, Jordan, et al.
Publicado: (2022) -
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review
por: Heiskanen, Aliisa, et al.
Publicado: (2022)